MLYS position history
The shares of Mineralys Therapeutics (MLYS) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 15,200 shares, $131K, 0.03% of portfolio, New
- 2024 Q1: 90,000 shares, $1.2M, 0.26% of portfolio, Add +492.1%
- 2024 Q2: 119,000 shares, $1.4M, 0.33% of portfolio, Add +32.2%
- 2024 Q3: 146,500 shares, $1.8M, 0.42% of portfolio, Add +23.1%
- 2024 Q4: 146,500 shares, $1.8M, 0.46% of portfolio
- 2025 Q1: 309,200 shares, $4.9M, 1.4% of portfolio, Add +111.1%
- 2025 Q2: 371,523 shares, $5M, 1.4% of portfolio, Add +20.2%
- 2025 Q3: 83,490 shares, $3.2M, 0.78% of portfolio, Reduce −77.5%
- 2025 Q4: 38,490 shares, $1.4M, 0.32% of portfolio, Reduce −53.9%
- 2026 Q1: 38,490 shares, $1M, 0.24% of portfolio
- 2026 Q2: 44,490 shares, $1.2M, 0.23% of portfolio, Add +15.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|